Opinion

ANSES OPINION on a “pest risk analysis for huanglongbing disease in the European Union”

ANSES OPINION on a “pest risk analysis for huanglongbing disease in the European Union”

Read time: 0 mins

ANSES OPINION on the risks associated with ingestion of the food additive E171

ANSES OPINION on the risks associated with ingestion of the food additive E171

Read time: 0 mins

ANSES OPINION on the “Health effects associated with exposure to low-frequency electromagnetic fields”

ANSES OPINION on the “Health effects associated with exposure to low-frequency electromagnetic fields”

Read time: 0 mins

ANSES OPINION on the “effects on human health and the environment (fauna and flora) of systems using light-emitting diodes (LEDs)”

ANSES OPINION on the “effects on human health and the environment (fauna and flora) of systems using light-emitting diodes (LEDs)”

Read time: 0 mins

ANSES OPINION on the assessment of the health risks associated with pinnatoxins in shellfish

ANSES OPINION on the assessment of the health risks associated with pinnatoxins in shellfish

Read time: 0 mins

ANSES Revised OPINION on the safety of baby diapers

ANSES Revised OPINION on the safety of baby diapers

Read time: 0 mins

ANSES OPINION on a case of severe hypokalaemia following misuse of the food supplement Rhubarbe® containing liquorice

ANSES OPINION on a case of severe hypokalaemia following misuse of the food supplement Rhubarbe® containing liquorice

Read time: 0 mins

OPINION and REPORT on the "assessment of a warning signal regarding the toxicity of succinate dehydrogenase inhibitor (SDHI) fungicides"

OPINION and REPORT on the "assessment of a warning signal regarding the toxicity of succinate dehydrogenase inhibitor (SDHI) fungicides"

Read time: 0 mins

ANSES OPINION on the proposed TRV by the oral route for microcystin-LR (CAS No. 101043-37-2)

ANSES OPINION on the proposed TRV by the oral route for microcystin-LR (CAS No. 101043-37-2)

Read time: 0 mins

ANSES OPINION on the proposed subchronic TRV by the oral route for cylindrospermopsin (CAS No. 143545-90-8)

ANSES OPINION on the proposed subchronic TRV by the oral route for cylindrospermopsin (CAS No. 143545-90-8)

Read time: 0 mins

Pages